Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

14.52
+0.09000.62%
Volume:303.46K
Turnover:4.43M
Market Cap:389.39M
PE:-82.91
High:14.89
Open:14.56
Low:14.25
Close:14.43
Loading ...

B. Riley Raises Price Target on Eton Pharmaceuticals to $26 From $24, Keeps Buy Rating

MT Newswires Live
·
16 May

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
15 May

Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Eton Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase

MT Newswires Live
·
14 May

Eton Pharmaceuticals Q1 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $17.28M Beat $15.13M Estimate

Benzinga
·
14 May

BRIEF-Eton Pharmaceuticals Q1 Net Income USD -1.572 Million

Reuters
·
14 May

Eton Pharmaceuticals Reports Q1 2025 Revenue Surge of 76%, Achieves Non-GAAP EPS of $0.07 Despite GAAP EPS Loss of $(0.06)

Reuters
·
14 May

Eton Pharmaceuticals Inc expected to post earnings of 5 cents a share - Earnings Preview

Reuters
·
10 May

Eton Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
02 May

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

GlobeNewswire
·
02 May

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks
·
01 May

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Apellis Pharmaceuticals (APLS) and Eton Pharmaceuticals (ETON)

TIPRANKS
·
28 Apr

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus

MT Newswires Live
·
28 Apr

BRIEF-Eton Pharmaceuticals Says FDA Review Expected To Take 10 Months, Potential Q1 2026 Launch

Reuters
·
28 Apr

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

GlobeNewswire
·
28 Apr

B.Riley Financial Remains a Buy on Eton Pharmaceuticals (ETON)

TIPRANKS
·
17 Apr

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

Simply Wall St.
·
15 Apr

BUZZ-Eton Pharma falls after co licenses rare disease drug to Spanish company

Reuters
·
01 Apr

Craig-Hallum Sticks to Their Buy Rating for Eton Pharmaceuticals (ETON)

TIPRANKS
·
01 Apr

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals

MT Newswires Live
·
01 Apr